Targeting cadherin-17 inactivates wnt signaling and inhibits tumor growth in liver carcinoma (Hepatology (2009) 50, DOI: 10.1002/hep.23143)

by Luk, J.M.
Published 2016

Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma

by Wong, K.-F., Luk, J.M.
Published 2014

Proteomics of hepatocellular carcinoma in chinese patients

by Luk, J.M., Liu, A.M.
Published 2014

An update on targeting Hippo-YAP signaling in liver cancer

by Liu, A.M., Xu, Z., Luk, J.M.
Published 2014

Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents

by Wong, K.-F., Yuan, Y., Luk, J.M.
Published 2016

Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: Pathogenesis and therapeutic implications

by Chan, K.L., Wong, K.F., Luk, J.M.
Published 2016

Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma

by Chung, Y., Law, S., Kwong, D.L.W., Luk, J.M.
Published 2016

Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma

by Wong, K.-F, Liu, A.M, Hong, W, Xu, Z, Luk, J.M
Published 2020

Regulators of mammalian Hippo pathway in cancer

by Liu, A.M., Wong, K.-F., Jiang, X., Qiao, Y., Luk, J.M.
Published 2014

Circulating markers for prognosis of hepatocellular carcinoma

by Wong, K.-F., Xu, Z., Chen, J., Lee, N.P., Luk, J.M.
Published 2014

Prophylactic uses of integrin CD18-βA peptide in a murine polymicrobial peritonitis model

by Wong, K.-F., Wo, J., Ho, D., Poon, R.T., Casasnovas, J.M., Luk, J.M.
Published 2014

Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma

by Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M.
Published 2016

HNF1α and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma

by Zhu, R., Wong, K.-F., Lee, N.P.Y., Lee, K.-F., Luk, J.M.C.
Published 2014

Global Regulation on microRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma

by Liu, A.M., Zhang, C., Burchard, J., Fan, S.T., Wong, K.-F., Dai, H., Poon, R.T., Luk, J.M.
Published 2014

Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 Expression

by Li J., Lau G., Chen L., Yuan Y.-F., Huang J., Luk J.M., Xie D., Guan X.-Y.
Published 2020

Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma

by Huo, X., Zhang, Q., Liu, A.M., Tang, C., Gong, Y., Bian, J., Luk, J.M., Xu, Z., Chen, J.
Published 2014

MiR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma

by Liu, A.M., Xu, Z., Shek, F.H., Wong, K.-F., Lee, N.P., Poon, R.T., Chen, J., Luk, J.M.
Published 2014

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study

by Liu, A.M., Yao, T.-J., Wang, W., Wong, K.-F., Lee, N.P., Fan, S.T., Poon, R.T.P., Gao, C., Luk, J.M.
Published 2014

Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm)

by Sun, S., Poon, R.T.P., Lee, N.P., Yeung, C., Chan, K.L., Ng, I.O.L., Day, P.J.R., Luk, J.M.
Published 2016

Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo

by Rajendran, P., Li, F., Shanmugam, M.K., Kannaiyan, R., Goh, J., Wong, K., Wang, W., Khin, E., Tergaonkar, V., Kumar, A., Luk, J.M., Sethi, G.
Published 2014